In vivo evaluation of the new PHIL low viscosity in a swine rete mirabile model
- PMID: 29973081
- PMCID: PMC6259347
- DOI: 10.1177/1591019918784915
In vivo evaluation of the new PHIL low viscosity in a swine rete mirabile model
Abstract
Introduction: Few liquid embolic materials are available for treatment of arteriovenous malformations. We describe the in vivo experience with the new PHIL low viscosity (LV) liquid embolic agent in a swine rete mirabile model.
Methods: Eight swine were treated. Two animals underwent embolization of a rete with PHIL LV and the contralateral rete with Squid 12 (euthanized the same day). Six animals underwent embolization of the right rete: two with balloon flow arrest (euthanized at 14 d) and four with a microcatheter alone (euthanized at 14 and 90 d). Performance characteristics of the embolic agents were evaluated. Microscopic and histological analysis of the harvested retia was performed. Macroscopic examinations and high contrast digital-based radiographs of the central nervous system were obtained.
Results: We did not experience any technical complication during embolization of each rete. Overall occlusion ability, on/off injection and ease to retrieve the microcatheter/balloon with PHIL LV were optimal. Fluoroscopic visualization of the PHIL LV cast was adequate to optimal. Average embolization time with flow arrest was 9.5 min versus 19.5 min with microcatheter plugging. Embolizations with PHIL LV required less volume and were shorter when compared to Squid 12. Subacute (14 d) and chronic (90 d) microscopic and histological analysis demonstrated minimal inflammatory changes in the perivascular tissues and permanent occlusion of the embolized vasculature.
Conclusion: In this swine rete model, the new PHIL LV embolic agent had an excellent embolization performance. Vessels embolized remained occluded up to 90 d from the procedure with minimal inflammatory changes.
Keywords: AVM; dural arteriovenous fistula; embolic; rete.
Figures



References
-
- Samaniego EA, Kalousek V, Abdo G, et al. Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs. J Neurointerv Surg 2016; 8: 1253–1255. - PubMed
-
- Varadharajan S, Ramalingaiah AH, Saini J, et al. Precipitating hydrophobic injectable liquid embolization of intracranial vascular shunts: initial experience and technical note. J Neurosurg 2017; epub ahead of print, DOI: 10.3171/2017.6.JNS16447. - PubMed
-
- Vollherbst DF, Otto R, von Deimling A, et al. Evaluation of a novel liquid embolic agent (precipitating hydrophobic injectable liquid (PHIL)) in an animal endovascular embolization model. J Neurointerv Surg 2018; 10: 268–274. - PubMed
-
- Schwartz RS, Huber KC, Murphy JG, et al. Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992; 19: 267–274. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources